GSK:NYSE
GSK plc
50,45 $
arrow_upward
+0,52%(+0,26) 1D
50,45 $
0,00% (0,00)
bedtimePo zaprtju
Zaprto: 13. nov., 16:00:02 GMT -5 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za GSK …
Odpri
50,25 $
Visoka
50,80 $
Nizka
50,13 $
Tržna kapitalizacija
101,75 mrd.
Povprečni promet
5,06 mio.
Promet
2,78 mio.
Dividenda
3,64 %
Četrtletna dividenda
0,46 $
Prvi trgovalni dan brez upravičenja do dividende
12. nov. 2026
Razmerje med ceno delnice in čistim dobičkom
17,85
52-tedenski najvišji tečaj
61,70 $
52-tedenski najnižji tečaj
45,80 $
Čisti dobiček na delnico
2,83 $
Beta
0,20
Št. izdanih delnic
2,02 mrd.
Št. zaposlenih
67 tis.
Odpri
50,25 $
Visoka
50,80 $
Nizka
50,13 $
Tržna kapitalizacija
101,75 mrd.
Povprečni promet
5,06 mio.
Promet
2,78 mio.
Dividenda
3,64 %
Četrtletna dividenda
0,46 $
Prvi trgovalni dan brez upravičenja do dividende
12. nov. 2026
Razmerje med ceno delnice in čistim dobičkom
17,85
52-tedenski najvišji tečaj
61,70 $
52-tedenski najnižji tečaj
45,80 $
Čisti dobiček na delnico
2,83 $
Beta
0,20
Št. izdanih delnic
2,02 mrd.
Št. zaposlenih
67 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
JournalArta
·
pred 8 urami
GSK Stock Week Ahead: Levels and Scenarios for November 16–20
Zacks
·
pred 1 dnevom
Can Gilead Sciences' HIV Business Fuel Sustainable Long-Term Growth?
Traders Union
·
pred 2 dnevoma
Why is GSK stock up 1.6% today?
The Globe and Mail
·
pred 2 dnevoma
Deutsche Bank Remains a Hold on GlaxoSmithKline (GSK)
Profil
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Vizitka: GSK plc
Generalni direktorEmma Walmsley | Emma Walmsley
Št. zaposlenih66,8 tis.
Ustanovljeno27. dec. 2000
Sedež-
SektorHealth Care
Panoga-
Spletno mestogsk.com